Ann & Robert H. Lurie Children’s Hospital
This page includes a searchable index of all resources created by Ann & Robert H. Lurie Children’s Hospital and Northwestern University. If you would like to add a resource to this index, please contact us.
Q and A: Vaccine Ingredients: What You Should Know
This fact sheet describes why certain ingredients like aluminum, formaldehyde, gelatin, and mercury are used in vaccines and explains that the amounts are very small …
Q and A: The Facts About Vaccine Safety: What You Should Know
This two-page fact sheet is for families concerned about vaccine safety. While vaccines can have mild side effects, the risks from not getting vaccinated are …
The Child Opportunity Index and Pediatric Emergency Medical Services Utilization
2023
· Ann and Robert H. Lurie Children’s Hospital,
· Northwestern University,
· The University of Chicago Medicine,
· Children's Hospital of Pittsburgh,
· University of Pittsburgh,
· University of Florida
This article discusses how the Child Opportunity Index, which measures resources and conditions for children in different neighborhoods, relates to how often kids use emergency …
Deviation From National Dosing Recommendations for Children Having Out-Of-Hospital Emergencies
2023
· Ann and Robert H. Lurie Children’s Hospital,
· Northwestern University,
· University of Pittsburgh
This article is about a study examining how often medicine doses given to children in emergencies outside of hospitals differ from national guidelines. It describes …
Efficacy of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants With Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials
2023
· Children's Hospital Colorado,
· University of the Witwatersrand,
· Northwestern University,
· Dr. Georgi Stranski University Hospital,
· Quironsalud Madrid University Hospital,
· State University of New York - Upstate Medical University
This article describes a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) infections in infants. It focuses on both preterm and …
Primary Care Perspectives: Episode 154 - Nirsevimab (Beyfortus)
This podcast discusses a new preventative medicine called nirsevimab (Beyfortus), which is now available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). …
Preventing RSV in Babies: A Scientific Milestone
This 3-minute video discusses the use of nirsevimab (Beyfortus™) to protect vulnerable infants from RSV. Dr. Paul Offit explains its benefits, clinical trial results, and …
News & Views: Nirsevimab Means Brushing Up on Passive Immunity Talking Points
This post is about nirsevimab, a new treatment that helps protect babies from respiratory illnesses. It describes how nirsevimab provides passive immunity, which means it …
Using Hospital Incident Command Systems to Respond to the Pediatric Mental and Behavioral Health Crisis of the COVID-19 Pandemic
This article discusses how hospital incident command systems (HICS) were implemented to expand mental and behavioral healthcare (MBHC) services during the COVID-19 pandemic. Data on …
Standardizing and Improving Care for Pediatric Agitation Management in the Emergency Department
The article describes efforts to improve care for children with agitation in emergency departments. A team created a plan to standardize treatment, aiming to reduce …